SMO and ameloblastoma: While human ameloblastomas harbor driver mutations in the mitogen-activated protein kinase (MAPK) pathway (including BRAF, KRAS, NRAS, HRAS and FGFR4) and Hedgehog pathway (SMO)11,12, the drivers of CAA have not been known.